Literature DB >> 21810380

Carotid intima-media thickness and paraoxonase activity in patients with ankylosing spondylitis.

Hasan Cece1, Pelin Yazgan, Ekrem Karakas, Omer Karakas, Ahmet Demirkol, Ismail Toru, Nurten Aksoy.   

Abstract

PURPOSE: The risk of atherosclerosis is increased in several rheumatological disorders, but any such risk remains unproven for ankylosing spondylitis. Since carotid intima-media thickness is an indicator of early atherosclerosis, and the paraoxonase (PON1) enzyme has antioxidant activity to prevent LDL oxidation, we aimed to identify: 1) the relationship between carotid intima-media thickness (CIMT) and serum paraoxonase (PON1) activity in ankylosing spondylitis (AS) patients; and 2) the possible differences in CIMT in AS patients versus age-matched, healthy controls.
METHODS: Forty-five AS patients (36.8±9.8 years, 36 males, 9 females) and 30 controls (35.9±10.2 years, 23 males, 7 females) were recruited consecutively. Serum PON1 activity and CIMT were measured. The Bath Ankylosing Spondylitis Metrology Index (BASMI), Bath Ankylosing Spondylitis Functional Index (BASFI), Bath Ankylosing Spondylitis Radiologic Index (BASRI) and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) were used to identify relationships between these clinical indices and levels of CIMT and PON1.
RESULTS: Mean CIMT was significantly increased in AS patients relative to controls (0.49±0.06 mm vs. 0.59±0.07 mm; p < 0.0001). Conversely, serum PON1 activity was decreased (199.1±60.3 U/L vs. 96.7±29 U/L; p < 0.0001). PON1 activity was negatively correlated with CIMT (r = -0.557, p = 0.0001). Disease duration was positively correlated with CIMT (r = 0.542, p = 0.0001) and negatively correlated with PON1 (r = -0.649, p = 0.0001). On multivariate analysis, disease duration and serum PON1 activity were found to be independent predictors of CIMT (R2 = 0.687, p = 0.0001).
CONCLUSIONS: In conclusion, significantly increased CIMT and decreased PON1 activity suggest a relationship between atherosclerosis and AS: a relationship that is strongly correlated with disease duration.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21810380     DOI: 10.25011/cim.v34i4.15364

Source DB:  PubMed          Journal:  Clin Invest Med        ISSN: 0147-958X            Impact factor:   0.825


  10 in total

1.  Evaluation of paraoxonase and arylesterase activities in Egyptian patients with ankylosing spondylitis.

Authors:  Shereem Mohamed Olama; Mohammed Mohamed Elarman
Journal:  Rheumatol Int       Date:  2012-12-14       Impact factor: 2.631

2.  Does metformin increase paraoxonase activity in patients with the metabolic syndrome? Additional data from the MEFISTO study.

Authors:  Eduardo Meaney; Patricia Sierra-Vargas; Alejandra Meaney; Martín Guzmán-Grenfell; Israel Ramírez-Sánchez; Juan Jose Hicks; Ivonne Olivares-Corichi; Guillermo Ceballos
Journal:  Clin Transl Sci       Date:  2012-06       Impact factor: 4.689

3.  Epicardial adipose tissue thickness in patients with ankylosing spondylitis.

Authors:  Hatice Resorlu; Ayla Akbal; Mustafa Resorlu; Ferhat Gokmen; Can Ates; Fatma Uysal; Gurhan Adam; Nilufer Aylanc; Muhammet Arslan; Besir Sahin İnceer
Journal:  Clin Rheumatol       Date:  2014-03-21       Impact factor: 2.980

4.  Increased risk of ischemic stroke in young patients with ankylosing spondylitis: a population-based longitudinal follow-up study.

Authors:  Chia-Wei Lin; Ya-Ping Huang; Yueh-Hsia Chiu; Yu-Tsun Ho; Shin-Liang Pan
Journal:  PLoS One       Date:  2014-04-08       Impact factor: 3.240

5.  Predictors of Atherosclerosis in Ankylosing Spondylitis.

Authors:  Inderjeet Verma; Pawan Krishan; Ashit Syngle
Journal:  Rheumatol Ther       Date:  2015-08-30

6.  Changes of Metabolic Biomarker Levels upon One-Year Anti-TNF-α Therapy in Rheumatoid Arthritis and Ankylosing Spondylitis: Associations with Vascular Pathophysiology.

Authors:  Monika Czókolyová; Anita Pusztai; Edit Végh; Ágnes Horváth; Anita Szentpéteri; Attila Hamar; Szilvia Szamosi; Katalin Hodosi; Andrea Domján; Sándor Szántó; György Kerekes; Ildikó Seres; Mariann Harangi; György Paragh; Éva Szekanecz; Zoltán Szekanecz; Gabriella Szűcs
Journal:  Biomolecules       Date:  2021-10-18

7.  Evaluation of Atrial Conduction Times, Epicardial Fat Thickness and Carotid Intima-Media Thickness in Patients With Ankylosing Spondylitis.

Authors:  Sabri Onur Çağlar; İsmail Boyraz; Fatma Erdem; Selma Yazici; Hilal Çağlar; Bünyamin Koç; Emrah Çağlar; Mehmet Yazici
Journal:  Arch Rheumatol       Date:  2016-06-03       Impact factor: 1.472

8.  Carotid intima media thickness as a marker of atherosclerosis in ankylosing spondylitis.

Authors:  Naveen Gupta; Renu Saigal; Laxmikant Goyal; Abhishek Agrawal; Rajat Bhargava; Arun Agrawal
Journal:  Int J Rheumatol       Date:  2014-04-07

9.  Evaluation of single nucleotide polymorphisms in 6 candidate genes and carotid intima-media thickness in community-dwelling residents.

Authors:  Fang-Yang Wu; Chia-Ing Li; Li-Na Liao; Chiu-Shong Liu; Wen-Yuan Lin; Chih-Hsueh Lin; Chuan-Wei Yang; Tsai-Chung Li; Cheng-Chieh Lin
Journal:  PLoS One       Date:  2020-03-26       Impact factor: 3.240

10.  Assessment of subclinical atherosclerotic cardiovascular disease in patients with ankylosing spondylitis.

Authors:  Erdinç Hatipsoylu; İlker Şengül; Taciser Kaya; Altınay Göksel Karatepe; Seniz Akçay; Leyla Isayeva; Giray Bozkaya; Erhan Tatar
Journal:  Anatol J Cardiol       Date:  2019-09       Impact factor: 1.596

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.